Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
465
Price
$547.77
Total Value
$254.71K
Shares Held After
26,012
% of Holdings
1.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
504
Price
$546.54
Total Value
$275.45K
Shares Held After
26,477
% of Holdings
1.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
855
Price
$545.63
Total Value
$466.52K
Shares Held After
26,981
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
560
Price
$543.50
Total Value
$304.36K
Shares Held After
27,836
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
240
Price
$541.61
Total Value
$129.99K
Shares Held After
28,396
% of Holdings
0.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
45
Price
$540.64
Total Value
$24.33K
Shares Held After
28,636
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
74
Price
$539.46
Total Value
$39.92K
Shares Held After
28,681
% of Holdings
0.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Jun 15, 2026
Sale
Shares
121
Price
$538.52
Total Value
$65.16K
Shares Held After
28,755
% of Holdings
0.4%
Jun 15, 2026
Purchase
Shares
2,067
Price
$2.22
Total Value
$4.59K
Shares Held After
19,198
% of Holdings
10.8%
Jun 15, 2026
Purchase
Shares
2,465
Price
$2.22
Total Value
$5.47K
Shares Held After
12,435
% of Holdings
19.8%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Jun 15, 2026
Purchase
Shares
2,654
Price
$2.22
Total Value
$5.89K
Shares Held After
13,412
% of Holdings
19.8%

BRUKER CORP (BRKR)

Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Jun 15, 2026
Sale
Shares
2,000
Price
$54.76
Total Value
$109.52K
Shares Held After
128,443
% of Holdings
1.5%

Aquestive Therapeutics, Inc. (AQST)

Barber Daniel — President and CEO
Jun 15, 2026
Sale
Shares
25,000
Price
$4.16
Total Value
$104.01K
Shares Held After
635,574
% of Holdings
3.8%

Immuneering Corp (IMRX)

Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Jun 15, 2026
Purchase
Shares
6,035
Price
$4.15
Total Value
$25.05K
Shares Held After
382,531
% of Holdings
1.6%

RadNet, Inc. (RDNT)

Forthuber Stephen M — Pres & CEO-Eastern Operations
Jun 15, 2026
Sale
Shares
19,853
Price
$58.61
Total Value
$1.16M
Shares Held After
507,199
% of Holdings
3.8%

RadNet, Inc. (RDNT)

Forthuber Stephen M — Pres & CEO-Eastern Operations
Jun 15, 2026
Sale
Shares
24,214
Price
$57.79
Total Value
$1.40M
Shares Held After
527,052
% of Holdings
4.4%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick — Chief Business - Strategy Off
Jun 15, 2026
Purchase
Shares
1,831
Price
$2.22
Total Value
$4.06K
Shares Held After
11,007
% of Holdings
16.6%

Liquidia Corp (LQDA)

Bloch Stephen M — Director
Jun 15, 2026
Sale
Shares
2,322
Price
$72.08
Total Value
$167.36K
Shares Held After
980,073
% of Holdings
0.2%

Liquidia Corp (LQDA)

Bloch Stephen M — Director
Jun 15, 2026
Sale
Shares
82,740
Price
$71.42
Total Value
$5.91M
Shares Held After
982,395
% of Holdings
7.8%

STERIS plc (STE)

Zangerle John Adam — Sr. VP, Gen Counsel, and Sec.
Jun 15, 2026
Sale
Shares
1,419
Price
$209.28
Total Value
$296.97K
Shares Held After
35,259
% of Holdings
3.9%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy — Chief Administrative Officer
Jun 15, 2026
Purchase
Shares
2,118
Price
$2.22
Total Value
$4.70K
Shares Held After
11,958
% of Holdings
17.7%

Immunovant, Inc. (IMVT)

Pande Atul — Director
Jun 15, 2026
Sale
Shares
1,500
Price
$34.02
Total Value
$51.03K
Shares Held After
116,731
% of Holdings
1.3%

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reynoso Jamie L. — CEO, Medicare Advantage
Jun 15, 2026
Sale
Shares
6,350
Price
$4.61
Total Value
$29.27K
Shares Held After
2,843,571
% of Holdings
0.2%
Jun 15, 2026
Sale
Shares
4,681
Price
$4.61
Total Value
$21.58K
Shares Held After
1,567,741
% of Holdings
0.3%
Jun 15, 2026
Purchase
Shares
1,587,301
Price
$1.26
Total Value
$2.00M
Shares Held After
36,119,086
% of Holdings
4.4%

Cytosorbents Corp (CTSO)

MARIANI PETER J — Chief Financial Officer
Jun 15, 2026
Purchase
Shares
100,000
Price
$0.44
Total Value
$44.00K
Shares Held After
638,113
% of Holdings
15.7%

111, Inc. (YI)

Sun Jian David — Director
Jun 15, 2026
Sale
Shares
58,800
Price
$0.23
Total Value
$13.52K
Shares Held After
413,211
% of Holdings
12.5%

111, Inc. (YI)

Chen Yang Luke — Director
Jun 15, 2026
Sale
Shares
44,000
Price
$0.23
Total Value
$10.12K
Shares Held After
495,462
% of Holdings
8.2%
Jun 15, 2026
Sale
Shares
3,666
Price
$3.58
Total Value
$13.12K
Shares Held After
132,715
% of Holdings
2.7%
Jun 15, 2026
Sale
Shares
30,000
Price
$19.55
Total Value
$586.42K
Shares Held After
947,313
% of Holdings
3.1%
Jun 15, 2026
Sale
Shares
18,160
Price
$5.71
Total Value
$103.70K
Shares Held After
119,562
% of Holdings
13.2%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Jun 15, 2026
Sale
Shares
600
Price
$69.69
Total Value
$41.81K
Shares Held After
236,384
% of Holdings
0.3%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Jun 15, 2026
Sale
Shares
733
Price
$69.69
Total Value
$51.08K
Shares Held After
31,034
% of Holdings
2.3%

Ultragenyx Pharmaceutical Inc. (RARE)

Parschauer Karah Herdman — EVP and Chief Legal Officer
Jun 15, 2026
Sale
Shares
1,899
Price
$24.62
Total Value
$46.75K
Shares Held After
94,462
% of Holdings
2.0%
Shares
2,000
Price
$25.05
Total Value
$50.10K
Shares Held After
21,095
% of Holdings
8.7%
Jun 15, 2026
Sale
Shares
1,729
Price
$69.69
Total Value
$120.49K
Shares Held After
925,580
% of Holdings
0.2%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Jun 15, 2026
Sale
Shares
947
Price
$69.69
Total Value
$66.00K
Shares Held After
32,718
% of Holdings
2.8%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Jun 15, 2026
Sale
Shares
300
Price
$70.62
Total Value
$21.19K
Shares Held After
33,665
% of Holdings
0.9%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Jun 15, 2026
Sale
Shares
5,064
Price
$69.42
Total Value
$351.55K
Shares Held After
33,965
% of Holdings
13.0%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Jun 15, 2026
Sale
Shares
1,636
Price
$68.38
Total Value
$111.88K
Shares Held After
39,029
% of Holdings
4.0%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Jun 15, 2026
Sale
Shares
395
Price
$69.69
Total Value
$27.53K
Shares Held After
16,899
% of Holdings
2.3%
Jun 15, 2026
Purchase
Shares
10,333
Price
$0.43
Total Value
$4.44K
Shares Held After
1,744,432
% of Holdings
0.6%

CYTOKINETICS INC (CYTK)

Blum Robert I — Director
Jun 15, 2026
Sale
Shares
7,500
Price
$70.46
Total Value
$528.45K
Shares Held After
385,330
% of Holdings
1.9%
Jun 15, 2026
Purchase
Shares
9,985
Price
$10.02
Total Value
$100.00K
Shares Held After
61,849
% of Holdings
16.1%

Jushi Holdings Inc. (JUSH/JUSHF)

MOSIER MICHELLE O — Chief Financial Officer
Jun 12, 2026
Purchase
Shares
1,000
Price
$0.49
Total Value
$486.90
Shares Held After
123,233
% of Holdings
0.8%

Jushi Holdings Inc. (JUSH/JUSHF)

MOSIER MICHELLE O — Chief Financial Officer
Jun 12, 2026
Purchase
Shares
2,500
Price
$0.49
Total Value
$1.22K
Shares Held After
125,733
% of Holdings
2.0%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Jun 12, 2026
Sale
Shares
1,605
Price
$219.36
Total Value
$352.07K
Shares Held After
2,327,843
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Jun 12, 2026
Sale
Shares
2,133
Price
$218.17
Total Value
$465.36K
Shares Held After
2,329,448
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Jun 12, 2026
Sale
Shares
4,276
Price
$217.32
Total Value
$929.28K
Shares Held After
2,331,581
% of Holdings
0.2%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Jun 12, 2026
Sale
Shares
7,182
Price
$216.51
Total Value
$1.55M
Shares Held After
2,335,857
% of Holdings
0.3%
Version: v26.5.2